Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

606 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth.
Lawler J. Lawler J. J Cell Mol Med. 2002 Jan-Mar;6(1):1-12. doi: 10.1111/j.1582-4934.2002.tb00307.x. J Cell Mol Med. 2002. PMID: 12003665 Free PMC article. Review.
Thrombospondin-1-deficient mice are not protected from bleomycin-induced pulmonary fibrosis.
Ezzie ME, Piper MG, Montague C, Newland CA, Opalek JM, Baran C, Ali N, Brigstock D, Lawler J, Marsh CB. Ezzie ME, et al. Among authors: lawler j. Am J Respir Cell Mol Biol. 2011 Apr;44(4):556-61. doi: 10.1165/rcmb.2009-0019OC. Epub 2010 Jun 25. Am J Respir Cell Mol Biol. 2011. PMID: 20581099 Free PMC article.
Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts.
Frangogiannis NG, Ren G, Dewald O, Zymek P, Haudek S, Koerting A, Winkelmann K, Michael LH, Lawler J, Entman ML. Frangogiannis NG, et al. Among authors: lawler j. Circulation. 2005 Jun 7;111(22):2935-42. doi: 10.1161/CIRCULATIONAHA.104.510354. Epub 2005 May 31. Circulation. 2005. PMID: 15927970
Thrombospondin 1--a regulator of adenoma growth and carcinoma progression in the APC(Min/+) mouse model.
Gutierrez LS, Suckow M, Lawler J, Ploplis VA, Castellino FJ. Gutierrez LS, et al. Among authors: lawler j. Carcinogenesis. 2003 Feb;24(2):199-207. doi: 10.1093/carcin/24.2.199. Carcinogenesis. 2003. PMID: 12584168
Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.
Daniel C, Schaub K, Amann K, Lawler J, Hugo C. Daniel C, et al. Among authors: lawler j. Diabetes. 2007 Dec;56(12):2982-9. doi: 10.2337/db07-0551. Epub 2007 Sep 18. Diabetes. 2007. PMID: 17878288
Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.
Cursiefen C, Maruyama K, Bock F, Saban D, Sadrai Z, Lawler J, Dana R, Masli S. Cursiefen C, et al. Among authors: lawler j. J Exp Med. 2011 May 9;208(5):1083-92. doi: 10.1084/jem.20092277. Epub 2011 May 2. J Exp Med. 2011. PMID: 21536744 Free PMC article.
The angiogenesis inhibitor thrombospondin-1 inhibits acute cutaneous hypersensitivity reactions.
Velasco P, Huegel R, Brasch J, Schröder JM, Weichenthal M, Stockfleth E, Schwarz T, Lawler J, Detmar M, Lange-Asschenfeldt B. Velasco P, et al. Among authors: lawler j. J Invest Dermatol. 2009 Aug;129(8):2022-30. doi: 10.1038/jid.2008.447. Epub 2009 Feb 5. J Invest Dermatol. 2009. PMID: 19194474
Thrombospondin-1-Based Antiangiogenic Therapy.
Sims JN, Lawler J. Sims JN, et al. Among authors: lawler j. J Ocul Pharmacol Ther. 2015 Sep;31(7):366-70. doi: 10.1089/jop.2015.0018. Epub 2015 Jun 3. J Ocul Pharmacol Ther. 2015. PMID: 26352160 Free PMC article.
Thrombospondin-1 in a Murine Model of Colorectal Carcinogenesis.
Lopez-Dee ZP, Chittur SV, Patel H, Chinikaylo A, Lippert B, Patel B, Lawler J, Gutierrez LS. Lopez-Dee ZP, et al. Among authors: lawler j. PLoS One. 2015 Oct 13;10(10):e0139918. doi: 10.1371/journal.pone.0139918. eCollection 2015. PLoS One. 2015. PMID: 26461935 Free PMC article.
Thrombospondin-1: an islet endothelial cell signal of importance for β-cell function.
Olerud J, Mokhtari D, Johansson M, Christoffersson G, Lawler J, Welsh N, Carlsson PO. Olerud J, et al. Among authors: lawler j. Diabetes. 2011 Jul;60(7):1946-54. doi: 10.2337/db10-0277. Epub 2011 May 26. Diabetes. 2011. PMID: 21617177 Free PMC article.
606 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page